Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

When Novo Nordisk slashed the prices of its insulin products, pharmacy benefit managers blocked access to some consumers by excluding some forms of insulin from the lists of drugs consumers can ...

This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...

Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Gov. Brian Kemp, though, vetoed a related bill that ...